GEMVAX AS has a total of 52 patent applications. Its first patent ever was published in 1990. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COLLATERAL THERAPEUTICS, IST SUPERIORE SANITA and MEDIGENE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Australia | 8 | |
#3 | United States | 8 | |
#4 | Norway | 6 | |
#5 | Canada | 4 | |
#6 | Argentina | 3 | |
#7 | Japan | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Hong Kong | 2 | |
#10 | Hungary | 2 | |
#11 | Czechia | 1 | |
#12 | Poland | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Gaudernack Gustav | 46 |
#2 | Eriksen Jon Amund | 41 |
#3 | Gjertsen Marianne Klemp | 22 |
#4 | Moller Mona | 20 |
#5 | Saeterdal Ingvil | 20 |
#6 | Moeller Mona | 16 |
#7 | Saeboe-Larssen Stein | 13 |
#8 | Saeboe-Larsen Stein | 6 |
#9 | Møller Mona | 5 |
#10 | Saeboee-Larsen Stein | 4 |
Publication | Filing date | Title |
---|---|---|
AU2013200550A1 | Polypeptides | |
WO2013135266A1 | Treatment of non-small cell lung carcinoma by active immunotherapy | |
AU5451699A | Peptides | |
US7030211B1 | Antigenic peptides derived from telomerase |